YAP Promotes Malignant Progression of <i>Lkb1</i> -Deficient Lung Adenocarcinoma through Downstream Regulation of Survivin
Wenjing Zhang(Shanghai Institutes for Biological Sciences), Hongbin Ji(ShanghaiTech University), Zhongzhou Yang(Fudan University), Shun Yao(Chinese Academy of Sciences), Yijun Gao(Shanghai Institutes for Biological Sciences), Fei Long(Second Military Medical University), Xinyuan Tong(Shanghai Jiao Tong University), Lei Zhang(Nanjing University of Chinese Medicine), Fuming Li(Fudan University), Yan Ren(Shanghai Institutes for Biological Sciences), Xiangkun Han(Chinese Academy of Sciences), Heng‐Yu Fan(Zhejiang University)
Cited by 89
Related Papers
Stem Cell Factor SOX2 Confers Ferroptosis Resistance in Lung Cancer via Upregulation of SLC7A11
|Cancer Research|2021|280
YAP Promotes Ovarian Cancer Cell Tumorigenesis and Is Indicative of a Poor Prognosis for Ovarian Cancer Patients
|PLoS ONE|2014|176
LKB1 Inactivation Elicits a Redox Imbalance to Modulate Non-small Cell Lung Cancer Plasticity and Therapeutic Response
|Cancer Cell|2015|167
The mTOR–S6K pathway links growth signalling to DNA damage response by targeting RNF168
|Nature Cell Biology|2018|140